A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis.
Wang D, Deng B, Cheng L, Li J, Zhang J, Zhang X, Guo X, Yan T, Yue X, An Y, Zhang B, Yang W, Xie J, Wang R.
Wang D, et al. Among authors: zhang b, zhang j, zhang x.
Acta Pharm Sin B. 2023 Feb;13(2):722-738. doi: 10.1016/j.apsb.2022.09.001. Epub 2022 Sep 5.
Acta Pharm Sin B. 2023.
PMID: 36873181
Free PMC article.